---
title: "IPO, Initial Public Offering | MedTech Terms"
description: "First sale of a company's stock to public investors via a registered SEC offering, typically on NYSE or Nasdaq."
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/ipo#term",
        "name": "Initial Public Offering",
        "alternateName": "IPO",
        "description": "An Initial Public Offering (IPO) is the first sale of a company's equity to public investors through a registered offering filed with the SEC under the Securities Act of 1933 (Form S-1). The process includes pre-filing organizational meetings, drafting the S-1 prospectus, SEC review, the road show, pricing, and listing on a national exchange (NYSE, Nasdaq). MedTech IPO windows are highly cyclical and typically require either commercial-stage revenue or late-stage clinical data with a near-term FDA decision.",
        "url": "https://medtechterms.com/terms/ipo",
        "termCode": "ipo",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/ipo#article",
        "headline": "IPO, Initial Public Offering",
        "description": "First sale of a company's stock to public investors via a registered SEC offering, typically on NYSE or Nasdaq.",
        "url": "https://medtechterms.com/terms/ipo",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/ipo"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/ipo#term"
        },
        "articleSection": "Investment & Finance",
        "inLanguage": "en",
        "keywords": "Initial Public Offering, IPO, Investment & Finance, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-09",
        "dateModified": "2026-05-09",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "SEC, Form S-1",
            "url": "https://www.sec.gov/forms",
            "publisher": {
              "@type": "Organization",
              "name": "SEC"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "SEC, Going Public",
            "url": "https://www.sec.gov/resources-small-businesses/going-public",
            "publisher": {
              "@type": "Organization",
              "name": "SEC"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "Silicon Valley Bank - Healthcare Reports",
            "url": "https://www.svb.com/trends-insights/",
            "publisher": {
              "@type": "Organization",
              "name": "SVB"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/m-and-a#term",
            "name": "Mergers and Acquisitions",
            "alternateName": "M&A",
            "url": "https://medtechterms.com/terms/m-and-a"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/liquidity-event#term",
            "name": "Liquidity Event",
            "url": "https://medtechterms.com/terms/liquidity-event"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/exit-multiple#term",
            "name": "Exit Multiple",
            "url": "https://medtechterms.com/terms/exit-multiple"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Investment & Finance",
            "item": "https://medtechterms.com/terms?cat=Investment%20%26%20Finance"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "Initial Public Offering",
            "item": "https://medtechterms.com/terms/ipo"
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Investment & Finance](/terms?cat=Investment%20%26%20Finance)
6.  /
7.  Initial Public Offering

[All terms](/terms)

Investment & Finance [Startup Lifecycle](/ecosystems/startup-lifecycle)IPO 

# Initial Public Offering

First sale of a company's stock to public investors via a registered SEC offering, typically on NYSE or Nasdaq.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 9, 2026 

## Definition

An Initial Public Offering (IPO) is the first sale of a company's equity to public investors through a registered offering filed with the SEC under the Securities Act of 1933 (Form S-1). The process includes pre-filing organizational meetings, drafting the S-1 prospectus, SEC review, the road show, pricing, and listing on a national exchange (NYSE, Nasdaq). MedTech IPO windows are highly cyclical and typically require either commercial-stage revenue or late-stage clinical data with a near-term FDA decision. 

## What this means in practice

For MedTech, the IPO is one of two primary liquidity paths (the other is  [M&A](/terms/m-and-a)). Public-company readiness imposes ongoing 10-K, 10-Q, 8-K, SOX 404, and Reg FD obligations that materially change operating cost. 

Common pitfalls

-   • Going public too early, public markets punish missed clinical or commercial milestones harshly. 
-   • Underestimating SOX 404(b) internal-control audit costs in the first post-IPO year. 

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Investment & Finance

Exit Multiple

Valuation ratio applied at exit, e.g., enterprise value to revenue.





](/terms/exit-multiple)[

Investment & Finance

Mergers and Acquisitions(M&A) 

Transactions in which one company acquires or combines with another, the dominant MedTech exit path, typically a strategic acquisition by an established player.





](/terms/m-and-a)[

Investment & Finance

Liquidity Event

Any transaction that converts illiquid private-company equity into cash or freely tradable securities, typically IPO, M&A, or secondary tender.





](/terms/liquidity-event)

### Founder & Investor Primer

· From this learning path 

[

Investment & Finance

Capitalization Table(Cap Table) 

Ledger of all securities issued by a company and who owns them.





](/terms/cap-table?from=founder-and-investor-primer)[

Investment & Finance

Convertible Note

Short-term debt that converts into equity at a future financing round.





](/terms/convertible-note?from=founder-and-investor-primer)[

Investment & Finance

Due Diligence

Investigation of a company before an investment, financing, or acquisition.





](/terms/due-diligence?from=founder-and-investor-primer)[

Investment & Finance

Series A / B / C Financing Rounds

Sequential priced equity rounds in venture-backed companies, typically progressing from product-market validation (A) to scale (B) to growth (C+).





](/terms/series-funding?from=founder-and-investor-primer)

### More in Investment & Finance

· Same category 

[

Investment & Finance

Strategic Investor

Corporate investor with operational, not just financial, motives.





](/terms/strategic-investor)

Cited by

Where this term appears across MedTech Terms.

Learning paths (1)

-   [Founder & Investor Primer](/paths/founder-and-investor-primer)Lesson 16 of 16 

Ecosystems (1)

-   [Startup Lifecycle](/ecosystems/startup-lifecycle)

## Primary references

3 sources 

Link health:  3 verified · last checked 2026-06-20 

SEC· 2 SVB· 1 

1.  [1 
    
    SEC, Form S-1
    
    Verified 
    
    SEC · sec.gov 
    
    
    
    ](https://www.sec.gov/forms)
2.  [2 
    
    SEC, Going Public
    
    Verified 
    
    SEC · sec.gov 
    
    
    
    ](https://www.sec.gov/resources-small-businesses/going-public)
3.  [3 
    
    Silicon Valley Bank - Healthcare Reports
    
    Verified 
    
    SVB · svb.com 
    
    
    
    ](https://www.svb.com/trends-insights/)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Diligencing a MedTech cybersecurity posture?

Blue Goat Cyber supports investors and acquirers with cybersecurity diligence on connected MedTech assets.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Investment & Finance

Acronym

IPO

Sources

3

Updated

5/9/2026

[Compare with another term](/compare?a=ipo)

Learn in 60 seconds

Card Lesson Quiz

First sale of a company's stock to public investors via a registered SEC offering, typically on NYSE or Nasdaq.

-   · For MedTech, the IPO is one of two primary liquidity paths (the other is M&A). 
-   · Public-company readiness imposes ongoing 10-K, 10-Q, 8-K, SOX 404, and Reg FD obligations that materially change operating cost. 
-   · The process includes pre-filing organizational meetings, drafting the S-1 prospectus, SEC review, the road show, pricing, and listing on a national exchange (NYSE, Nasdaq). 

Remember this

Watch out: Going public too early, public markets punish missed clinical or commercial milestones harshly.

Related terms

-   [Mergers and Acquisitions(M&A) ](/terms/m-and-a)
-   [Liquidity Event ](/terms/liquidity-event)
-   [Exit Multiple ](/terms/exit-multiple)

You may also need

Auto-suggested from Investment & Finance and shared keywords.

-   [Earn-Out ](/terms/earn-out)
-   [Drag-Along and Tag-Along Rights ](/terms/drag-tag-along)
-   [Due Diligence ](/terms/due-diligence)
-   [Royalty Financing ](/terms/royalty-financing)
-   [Special Purpose Acquisition Company(SPAC) ](/terms/spac)
-   [409A Valuation ](/terms/409a-valuation)

[All Investment & Finance terms](/terms?cat=Investment%20%26%20Finance)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)